Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 999 | 1208 | 1156 | 1043 | 1640 | 2603 |
Fund Return | -0.09% | 20.8% | 15.6% | 1.4% | 10.4% | 10.04% |
Place in category | 258 | 110 | 88 | 152 | 247 | 154 |
% in Category | 40 | 20 | 14 | 35 | 48 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guggenheim Risk Managed Real Estt I | 310.63M | 10.82 | 3.34 | 9.00 | ||
Guggenheim Mid Cap Value A | 290.8M | -2.10 | 9.01 | 7.44 | ||
Guggenheim Variable Funds Series A | 258.67M | 1.96 | 9.89 | 12.29 | ||
Guggenheim StylePlus - Large Core A | 258.54M | 1.98 | 9.53 | 11.84 | ||
Guggenheim Variable Funds Series J | 164.22M | -0.13 | 1.17 | 10.20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.3B | 19.74 | 8.41 | 13.11 | ||
T. Rowe Price Mid-Cap Growth I | 12.95B | 9.72 | 2.33 | - | ||
T. Rowe Price Mid-Cap Growth | 12.88B | 9.61 | 2.19 | 11.17 | ||
Vanguard Mid-Cap Growth Index Admir | 12.13B | 11.40 | 1.70 | 10.58 | ||
T. Rowe Price New Horizons I | 10.44B | 3.47 | -8.65 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Guggenheim Strategy III | - | 36.50 | - | - | |
Guggenheim Strategy II | - | 34.24 | - | - | |
Russell MidCap Growth Index Total Return | - | 7.95 | - | - | |
Guggenheim Ultra Short Duration Instl | - | 3.28 | - | - | |
United Therapeutics | US91307C1027 | 0.47 | 368.43 | -1.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review